PROSPECTIVE STUDY OF TREATMENT PATTERN, EFFECTIVENESS, AND SAFETY OF ZOLEDRONIC ACID (ZOL) THERAPY BEYOND 24 MONTHS IN PATIENTS (PTS) WITH MULTIPLE MYELOMA (MM) OR SOLID TUMOR BONE METASTASIS (STM)

van den Wyngaert, T; Delforge, Michel; Doyen, C; Duck, L; Wouters, K; Delabaye, I; Wouters, C; Wildiers, Hans

Annals Of Oncology

PROSPECTIVE STUDY OF TREATMENT PATTERN, EFFECTIVENESS, AND SAFETY OF ZOLEDRONIC ACID (ZOL) THERAPY BEYOND 24 MONTHS IN PATIENTS (PTS) WITH MULTIPLE MYELOMA (MM) OR SOLID TUMOR BONE METASTASIS (STM)

Author:

van den Wyngaert, T

Delforge, Michel ; Doyen, C ; Duck, L ; Wouters, K ; Delabaye, I ; Wouters, C ; Wildiers, Hans

Keywords:

Science & Technology, Life Sciences & Biomedicine, Oncology, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, 3202 Clinical sciences, 3211 Oncology and carcinogenesis

Annals Of Oncology PROSPECTIVE STUDY OF TREATMENT PATTERN, EFFECTIVENESS, AND SAFETY OF ZOLEDRONIC ACID (ZOL) THERAPY BEYOND 24 MONTHS IN PATIENTS (PTS) WITH MULTIPLE MYELOMA (MM) OR SOLID TUMOR BONE METASTASIS (STM)

Author:

Keywords:

Annals Of Oncology

PROSPECTIVE STUDY OF TREATMENT PATTERN, EFFECTIVENESS, AND SAFETY OF ZOLEDRONIC ACID (ZOL) THERAPY BEYOND 24 MONTHS IN PATIENTS (PTS) WITH MULTIPLE MYELOMA (MM) OR SOLID TUMOR BONE METASTASIS (STM)